Skip to main content
Figure 3 | BMC Endocrine Disorders

Figure 3

From: Chromium supplementation in non-obese non-diabetic subjects is associated with a decline in insulin sensitivity

Figure 3

Boxplot of the delta change in insulin sensitivity (M LBM/I by group: Chromium therapy group is divided into high serum chromium group (>3.1 μg/L); low serum chromium group (≤ 3.1 μg/L); and placebo group. High serum chromium group had had greater insulin resistance than participants in the low serum chromium group or the placebo group, p=0.02, p=0.05 respectively.

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us